Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Final Trades: Abbott Labs, Yields & more
02:04pm, Thursday, 28'th Sep 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Abbott (ABT) Rides on Nutrition Recovery Amid Low Testing Sales
12:02pm, Thursday, 28'th Sep 2023
Abbott's (ABT) Nutrition business has started showing signs of recovery since the beginning of 2023.
After Plunging -8.5% in 4 Weeks, Here's Why the Trend Might Reverse for Abbott (ABT)
11:18am, Thursday, 28'th Sep 2023
The heavy selling pressure might have exhausted for Abbott (ABT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in r
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Wednesday, 27'th Sep 2023
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's Why Investors Should Invest in Abbott (ABT) Stock Now
10:31am, Tuesday, 26'th Sep 2023
Investors are optimistic about Abbott (ABT) on strong growth in the Diagnostics business and upbeat guidance.
5 Dividend Aristocrats to Buy as Things Look Dicey for Wall Street
09:46am, Tuesday, 26'th Sep 2023
As stocks are subjected to bouts of volatility, place bets on dividend aristocrats like Caterpillar (CAT), Abbott Laboratories (ABT), McDonald's (MCD), Aflac (AFL) and Automatic Data Processing (ADP)
2 Stocks to Benefit from the Aging Population
06:31am, Tuesday, 26'th Sep 2023
While the direction of the stock markets is unpredictable, the growth of the aging population is entirely predictable. Along with an aging population come additional healthcare, beauty and wellness ne
Abbott (ABT) Closes Acquisition Deal of Bigfoot Biomedical
09:46am, Monday, 25'th Sep 2023
Abbott's (ABT) footprint in the diabetes care market is increased by the Bigfoot Biomedical acquisition.
3 Best Stocks to Buy in September and Hold Forever
07:41am, Sunday, 24'th Sep 2023
Kenvue is poised to make its mark as a great business with a new name. Abbott Labs has long-term upside in key healthcare end markets.
Abbott Stock: Bear vs. Bull
09:15am, Saturday, 23'rd Sep 2023
The company has grown revenue for more than a decade. However, 2023 has been a challenge as Covid testing ebbs.
Abbott India warns of potential laxative syrup shortages amid production halt
05:06pm, Friday, 22'nd Sep 2023
Abbott Laboratories' Indian unit has cautioned about potential shortages of two popular laxative syrups, Cremaffin and Duphalac, due to a production halt in India's Goa state.
Abbott India warns of laxatives shortage in tussle with Goa regulator
09:18am, Friday, 22'nd Sep 2023
Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited in India's Goa state, where drug inspectors have found lapses a
All You Need to Know About Abbott (ABT) Rating Upgrade to Buy
01:32pm, Wednesday, 20'th Sep 2023
Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Abbott (ABT) Broadens Electrophysiology Footprint With TactiFlex
12:47pm, Wednesday, 20'th Sep 2023
The successful deployment of Abbott's (ABT) TactiFlex Ablation Catheter, Sensor Enabled in Canada broadens the company's global footprint in the electrophysiology space.
Abbott (ABT) Unveils Connected Diabetes App With New Pact
12:02pm, Wednesday, 20'th Sep 2023
Abbott's (ABT) FreeStyle Libre portfolio is the world's top sensor-based CGM system, changing the lives of over 5 million people.
